Latest news

Curida and PCI Biotech have entered into a manufacturing agreement

Posted on Jul 1, 2016

Oslo, July 1, 2016 – The pharmaceutical Contract Development and Manufacturing Organization Curida has entered into a manufacturing agreement with the Norwegian biotech company PCI Biotech. Curida will manufacture Amphinex, the lead product candidate from PCI Biotech. Amphinex is currently undergoing international clinical trials for bile duct cancer, a rare cancer disease with a high […]

Pre-clinical research collaboration agreement with top-10 large pharma company extended

Posted on May 26, 2016

Oslo, May 26, 2016 – PCI Biotech reported today that the existing research collaboration agreement signed in September 2015 with an undisclosed top-10 large pharma company has been extended until the end of 2016. The aim of the research collaboration is to evaluate the synergistic effects of both parties’ technology platforms, to determine whether PCI […]

Minutes from Annual General Meeting 2016

Posted on May 19, 2016

Oslo, 19 May 2016. The Annual General Meeting in PCI Biotech Holding ASA took place on 19 May 2016. All proposals according to the call were approved. A new Board of Directors was elected and consists of the following members until the next Annual General Meeting: * Hans Peter Bøhn, chairman * Kjetil Taskén, member […]